跳至主要内容
临床试验/DRKS00009604
DRKS00009604已完成未知

Standardized Evaluation of SPIDIMAn Glucose Monitoring System under routine environmental conditions - SPIDIMAN-02

Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Abteilung für Endokrinologie und Diabetologie0 个研究点目标入组 12 人开始时间: 2015年12月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 64 Years(—)
性别
All

入选标准

  • Informed consent obtained after being advised of the nature of the study;
  • Male or female aged =18 years;
  • Type 1 diabetes for at least 6 months according to the WHO definition;
  • Treatment with multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII) for at least 3 months;
  • Body Mass Index (BMI) < 35 kg/m²;
  • Willing and able to wear 4 CGM devices for the duration of the study and undergo all study procedures;
  • HbA1c = 86 mmol/mol

排除标准

  • Any disease or condition which the investigator feels would interfere with the trial or the safety of the subject
  • Female of childbearing potential who is pregnant, breast-feeding or intend to become
  • pregnant or is not using adequate contraceptive methods
  • Any mental condition rendering the subject incapable of giving his consent
  • Subject is using a medication that significantly impacts glucose metabolism (oral steroids) except if stable for at least the last three months and expected to remain stable for the study duration
  • Has severe medical or psychological condition(s) or chronic conditions/infections that in the opinion of the Investigator would compromise the subject’s safety or successful
  • participation in the study.
  • Subject is actively enrolled in another clinical trial
  • Subject donated blood in the last 3 months

研究者

发起方
Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Abteilung für Endokrinologie und Diabetologie

相似试验